Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia

Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia

It is believed that there are key differences in the genomic profile between adult and childhood acute myeloid leukemia (AML). Relapse is the significant contributor of mortality in patients with AML and remains as the leading cause of cancer death among children, posing great challenges in the trea...

Full description

Bibliographic Details
Main Authors: Habsah Aziz, Chow Y. Ping, Hamidah Alias, Nurul-Syakima Ab Mutalib, Rahman Jamal
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Pharmacology
Subjects:
acute myeloid leukemia
mutation
adult
childhood
relapse
biomarker
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00897/full

Internet

http://journal.frontiersin.org/article/10.3389/fphar.2017.00897/full

Similar Items